Evidence map›Paper›PMID 34660198›Full record

ArticleJournal of orthopaedic translation2021

Immobilization of bioactive vascular endothelial growth factor onto Ca-deficient hydroxyapatite-coated Mg by covalent bonding using polydopamine.

Junlei Li, Fang Cao, Bin Wu, Jiahui Yang, Wenwu Xu, Weidan Wang, Xiaowei Wei, Ge Liu, Dewei Zhao

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic translation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Biodegradable Cements for Bone Regeneration.Journal of functional biomaterials · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Bioengineered · 2022
    Article
  16. Article
  17. Review
  18. Review
  19. Silk fibroin scaffolds: A promising candidate for bone regeneration.Frontiers in bioengineering and biotechnology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Junlei LiDepartment of Orthopaedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, China.
Fang CaoDepartment of Biomedical Engineering, Faculty of Electronic Information and Electronical Engineering, Dalian University of Technology, Dalian, 116024, China.
Bin WuDepartment of Orthopaedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, China.
Jiahui YangDepartment of Orthopaedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, China.
Wenwu XuDepartment of Orthopaedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, China.
Weidan WangDepartment of Orthopaedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, China.
Xiaowei WeiDepartment of Orthopaedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, China.
Ge LiuDepartment of Orthopaedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, China.
Dewei ZhaoDepartment of Orthopaedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, China.
Affiliated Zhongshan Hospital of Dalian University · CNDalian University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBone tissue engineering (BTE) is considered a promising technology for repairing bone defects. Mg

methodsMg was firstly coated with Ca-deficient hydroxyapatite (CDHA) via hydrothermal treatment, and polydopamine (DOPA) was then used as the connecting medium to immobilize vascular endothelial growth factor (VEGF) on the CDHA coating. The physicochemical properties of the coatings were characterized by SEM, EDS, XPS, FTIR and immersion experiment in SBF. The ahesion, proliferation, and angiogenesis potential of the coatings were determined in vitro.

resultsThe composite coating significantly improved the corrosion resistance of Mg and prohibited excessively high local alkalinity. VEGF could be firmly immobilized on Mg via polydopamine. The CCK-8, live/dead staining and adhesion test results showed that the VEGF-DOPA-CDHA coating exhibited excellent biocompatibility and could significantly improve the adhesion and proliferation of MC3T3-E1 cells on Mg. Microtubule formation, immunofluorescence and Quantitative Real-Time PCR (qRT-PCR) experiments showed that VEGF immobilized on Mg still possessed bioactivity in promoting the differentiation of rat mesenchymal stem cells into endothelial cells.

conclusionIn this study, we enabled the angiogenic biological activity of Mg by immobilizing VEGF on Mg. Mg was successfully coated with a functional VEGF-DOPA-CDHA composite coating. The CDHA coating significantly increased the corrosion resistance of Mg and prohibited the negative effect of excessively high local alkalinity on the biological activity of VEGF. As an intermediate layer, the DOPA coating protects Mg, and DOPA provides a binding site for VEGF so that VEGF can be firmly immobilized on Mg and give Mg angiogenic bioactivity during the initial period of implantation. THE TRANSLATIONAL POTENTIAL OF THIS ARTICLE: The treatment of large bone defect is still one of the orthopedic trauma diseases that are difficult to be completely treated in clinic. The development of tissue engineering technology provides a new option for the treatment of large bone defects. The regeneration of blood vessels is of great significance for the repair of bone defects. In this study, VEGF was connected on the surface of degradable magnesium by covalent bonding. Vascular biofunctionalized magnesium scaffolds are expected to regenerate bone tissue with blood transport and be used in the clinical treatment of large bone defects.

Indexed as

AngiogenesisBone tissue engineeringMagnesiumVEGF

Identifiers

PMID34660198
PMCPMC8487887
OpenAlexW3204128655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.